Integrity® bare-metal coronary stent-induced platelet and endothelial cell activation results in a higher risk of restenosis compared to Xience® everolimus-eluting stents in stable angina patients-Reference-Cited by-同舟云学术

Integrity® bare-metal coronary stent-induced platelet and endothelial cell activation results in a higher risk of restenosis compared to Xience® everolimus-eluting stents in stable angina patients

Published:2016-01-14 Issue:5 Volume:27 Page:410-419
ISSN:0953-7104
Container-title:Platelets
language:en
Short-container-title:Platelets

Author:

Szük Tibor¹,Fejes Zsolt²,Debreceni Ildikó Beke²,Kerényi Adrienne²,Édes István¹,Kappelmayer János²,Jr Béla Nagy²

Affiliation:

1. Institute of Cardiology

2. Department of Laboratory Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary

Publisher

Informa UK Limited

Subject

Hematology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.3109/09537104.2015.1112368

Reference46 articles.

1. Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary Artery

2. Drug-eluting stents: the new gold standard for percutaneous coronary revascularisation

3. An insight into the current use of drug eluting stents in acute and elective percutaneous coronary interventions in Europe. A report on the EuroPCI Survey

4. Comparison of Six-Month Outcomes for Primary Percutaneous Revascularization for Acute Myocardial Infarction With Drug-Eluting Versus Bare Metal Stents (from the APEX-AMI Study)

5. Current status of the Xience V®everolimus-eluting coronary stent system

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of invasive therapeutic coronary interventions on endothelial cell activation and thrombin generation in patients with chronic total coronary occlusion;Thrombosis Research;2022-09

2. Soluble CD40 ligand and outcome in patients with coronary artery disease undergoing percutaneous coronary intervention;Clinical Chemistry and Laboratory Medicine (CCLM);2021-11-01

3. A heparin–rosuvastatin-loaded P(LLA-CL) nanofiber-covered stent inhibits inflammatory smooth-muscle cell viability to reduce in-stent stenosis and thrombosis;Journal of Nanobiotechnology;2021-04-29

4. A dramatic rise in serum ACE2 activity in a critically ill COVID-19 patient;International Journal of Infectious Diseases;2021-02

5. Inflammatory Growth Factors and In-Stent Restenosis: Effect of Cytokines and Growth Factors;SN Comprehensive Clinical Medicine;2020-03-02